Literature DB >> 29896971

Circulating miRNAs in blood and urine as diagnostic and prognostic biomarkers for bladder cancer: an update in 2017.

Angelika Tölle1,2, Conrad C Blobel1, Klaus Jung3.   

Abstract

This study presents a critical appraisal of previously published study data of miRNAs in blood, urine and exosomes as biomarkers of bladder cancer (BC). The evaluation included 39 articles published from the beginning of 2010 until September 2017 and searched in PubMed. The heterogeneity of studies, due to their clinicopathological variability, including insufficient consideration of diagnostic and prognostic biomarker guidelines and missing internal and external validation of data, do not currently allow the recommending of a useful miRNA marker as diagnostic or prognostic tool in BC. Future multi-institutional studies are necessary to overcome the deficiencies in these studies in order to prove the usefulness of circulating miRNAs as robust biomarkers for BC.

Entities:  

Keywords:  RT-PCR; biomarker; bladder cancer; diagnosis; miRNA; plasma; prognosis factor; reference gene urine; serum

Mesh：

Substances：

Year:  2018        PMID： 29896971     DOI： 10.2217/bmm-2017-0392

Source DB:  PubMed          Journal:  Biomark Med        ISSN： 1752-0363            Impact factor:   2.851


  7 in total

1.  Urinary microRNA and mRNA in Tumors.

Authors:  Erika Bandini
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Functional Implications and Clinical Potential of MicroRNAs in Irritable Bowel Syndrome: A Concise Review.

Authors:  Luis Alberto Bravo-Vázquez; Ixchel Medina-Ríos; Luis David Márquez-Gallardo; Josué Reyes-Muñoz; Francisco I Serrano-Cano; Surajit Pathak; Antara Banerjee; Anindya Bandyopadhyay; Asim K Duttaroy; Sujay Paul
Journal:  Dig Dis Sci       Date:  2022-05-04       Impact factor: 3.487

3.  Small Non-Coding RNA Profiling in Plasma Extracellular Vesicles of Bladder Cancer Patients by Next-Generation Sequencing: Expression Levels of miR-126-3p and piR-5936 Increase with Higher Histologic Grades.

Authors:  Alexandru A Sabo; Giovanni Birolo; Alessio Naccarati; Mihnea P Dragomir; Serena Aneli; Alessandra Allione; Marco Oderda; Marco Allasia; Paolo Gontero; Carlotta Sacerdote; Paolo Vineis; Giuseppe Matullo; Barbara Pardini
Journal:  Cancers (Basel)       Date:  2020-06-09       Impact factor: 6.639

4.  MiR-10a-5p: A Promising Biomarker for Early Diagnosis and Prognosis Evaluation of Bladder Cancer.

Authors:  Lei Yang; Hong-Fang Sun; Lin-Qing Guo; Hai-Bing Cao
Journal:  Cancer Manag Res       Date:  2021-10-14       Impact factor: 3.989

Review 5.  The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers.

Authors:  Ilaria Cavallari; Francesco Ciccarese; Evgeniya Sharova; Loredana Urso; Vittoria Raimondi; Micol Silic-Benussi; Donna M D'Agostino; Vincenzo Ciminale
Journal:  Cancers (Basel)       Date:  2021-11-23       Impact factor: 6.639

6.  A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancer.

Authors:  Mairah T Khan; Joely J Irlam-Jones; Ronnie Rodrigues Pereira; Brian Lane; Helen R Valentine; Kai Aragaki; Lars Dyrskjøt; David J McConkey; Peter J Hoskin; Ananya Choudhury; Catharine M L West
Journal:  Br J Cancer       Date:  2021-04-12       Impact factor: 7.640

7.  Evaluation of miR-130 family members as circulating biomarkers for the diagnosis of bladder cancer.

Authors:  Jingyao Wang; Liwen Zhao; Xiqi Peng; Kaihao Liu; Chunduo Zhang; Xuan Chen; Yanni Han; Yongqing Lai
Journal:  J Clin Lab Anal       Date:  2020-08-05       Impact factor: 3.124
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.